DK183590A - Fremgangsmaade til reduktion af immunoglobulin e-responser - Google Patents

Fremgangsmaade til reduktion af immunoglobulin e-responser Download PDF

Info

Publication number: DK183590A
Authority: DK; Denmark
Prior art keywords: responses; procedure; reducing immunoglobulin; antagonist; human interleukin
Prior art date: 1988-02-02

Application number

DK183590A

Other languages

English (en)

Other versions

DK183590D0 (da

Inventor

Robert L Coffman

Jan Egbert De Vries

Original Assignee

Schering Biotech Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-02-02

Filing date

1990-08-01

Publication date

1990-09-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22538655&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK183590(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1990-08-01 Application filed by Schering Biotech Corp filed Critical Schering Biotech Corp

1990-08-01 Publication of DK183590D0 publication Critical patent/DK183590D0/da

1990-09-27 Publication of DK183590A publication Critical patent/DK183590A/da

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- C07K16/247—IL-4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK183590A 1988-02-02 1990-08-01 Fremgangsmaade til reduktion af immunoglobulin e-responser DK183590A (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US15141388A	1988-02-02	1988-02-02
PCT/US1989/000285 WO1989006975A1 (en)	1988-02-02	1989-01-30	Method of reducing immunoglobulin e responses

Publications (2)

Publication Number	Publication Date
DK183590D0 DK183590D0 (da)	1990-08-01
DK183590A true DK183590A (da)	1990-09-27

Family

ID=22538655

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK183590A DK183590A (da)	1988-02-02	1990-08-01	Fremgangsmaade til reduktion af immunoglobulin e-responser

Country Status (20)

Country	Link
US (1)	US5676940A (da)
EP (2)	EP0397764A1 (da)
JP (1)	JPH03500050A (da)
KR (1)	KR900700132A (da)
AT (1)	ATE93144T1 (da)
AU (1)	AU629536B2 (da)
CA (1)	CA1341477C (da)
DE (1)	DE68908431T2 (da)
DK (1)	DK183590A (da)
ES (1)	ES2058490T3 (da)
FI (1)	FI903827A0 (da)
HK (1)	HK35196A (da)
HU (1)	HU211059B (da)
IE (1)	IE63097B1 (da)
IL (1)	IL89124A (da)
MY (1)	MY107079A (da)
NZ (1)	NZ227812A (da)
PT (1)	PT89573B (da)
WO (1)	WO1989006975A1 (da)
ZA (1)	ZA89766B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1990005183A1 (en)	1988-10-31	1990-05-17	Immunex Corporation	Interleukin-4 receptors
DK0504307T3 (da) *	1989-12-04	1994-03-21	Schering Corp	Fremgangsmåde til behandling af septisk shock
ES2085983T3 (es) *	1989-12-20	1996-06-16	Schering Corp	Antagonistas de anticuerpos de la interleuquina-4 humana.
US5252677A (en) *	1990-11-20	1993-10-12	Mitsubishi Petrochemical Company Limited	Functionalized olefin polymers
DE4137333A1 (de) *	1991-11-13	1993-05-19	W Prof Dr Sebald	Therapeutische mittel, die antagonisten oder partielle agonisten des humanen interleukin 4 sind oder diese enthalten, hil-4-mutantenproteine sowie vefahren zu deren herstellung
US5914110A (en) *	1993-09-07	1999-06-22	Smithkline Beecham Corporation	Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US20020193575A1 (en) *	1993-09-07	2002-12-19	Smithkline Beecham P.L.C.	Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US5928904A (en) *	1993-09-07	1999-07-27	Smithkline Beecham Corporation	DNA encoding recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US5597710A (en) *	1994-03-10	1997-01-28	Schering Corporation	Humanized monoclonal antibodies against human interleukin-4
US6911462B2 (en)	1998-05-22	2005-06-28	Avanir Pharmaceuticals	Benzimidazole compounds for regulating IgE
US6919366B2 (en)	1998-05-22	2005-07-19	Avanir Pharmaceuticals	Benzimidazole derivatives as modulators of IgE
US6759425B2 (en)	1999-10-21	2004-07-06	Avanir Pharmaceuticals	Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
EP2990420B1 (en)	2000-05-26	2016-12-21	Immunex Corporation	Use of interleukin-4 receptor antibodies and compositions thereof
BR0208010A (pt)	2001-03-12	2004-12-21	Avanir Pharmaceuticals	Composto de benzimidazol para modulação de ige e inibição de proliferação celular
TWI276631B (en)	2002-09-12	2007-03-21	Avanir Pharmaceuticals	Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
AU2003270426A1 (en)	2002-09-12	2004-04-30	Avanir Pharmaceuticals	PHENYL-INDOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION
AR050044A1 (es)	2004-08-03	2006-09-20	Novartis Ag	Anticuerpo especifico de il-4
US10196616B2 (en)	2017-02-15	2019-02-05	The United States Of America, As Represented By The Secretary Of Agriculture	Altered avian virus for in-ovo inoculation and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5041381A (en) *	1986-07-03	1991-08-20	Schering Corporation	Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
US5017691A (en) *	1986-07-03	1991-05-21	Schering Corporation	Mammalian interleukin-4
PT83761B (pt) *	1985-11-19	1989-06-30	Schering Biotech Corp	Metodo para a producao de interleuquina-4 de mamifero
EP0255547A1 (en) *	1986-07-29	1988-02-10	Kishimoto, Tadamitsu, Prof.	Monoclonal antibodies specific to surface receptor for IgE and hybrid cell lines producing these antibodies and use thereof
WO1989006138A1 (en) *	1987-12-31	1989-07-13	Tanox Biosystems, Inc.	UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES

1989
- 1989-01-30 AU AU30383/89A patent/AU629536B2/en not_active Expired
- 1989-01-30 EP EP89902151A patent/EP0397764A1/en active Pending
- 1989-01-30 EP EP89300872A patent/EP0327283B1/en not_active Revoked
- 1989-01-30 JP JP1502003A patent/JPH03500050A/ja active Pending
- 1989-01-30 ES ES89300872T patent/ES2058490T3/es not_active Expired - Lifetime
- 1989-01-30 HU HU891044A patent/HU211059B/hu unknown
- 1989-01-30 WO PCT/US1989/000285 patent/WO1989006975A1/en not_active Ceased
- 1989-01-30 AT AT89300872T patent/ATE93144T1/de not_active IP Right Cessation
- 1989-01-30 FI FI903827A patent/FI903827A0/fi not_active Application Discontinuation
- 1989-01-30 DE DE89300872T patent/DE68908431T2/de not_active Revoked
- 1989-01-30 KR KR1019890701803A patent/KR900700132A/ko not_active Ceased
- 1989-01-31 ZA ZA89766A patent/ZA89766B/xx unknown
- 1989-01-31 PT PT89573A patent/PT89573B/pt active IP Right Grant
- 1989-01-31 IL IL8912489A patent/IL89124A/en unknown
- 1989-01-31 NZ NZ227812A patent/NZ227812A/xx unknown
- 1989-01-31 MY MYPI89000118A patent/MY107079A/en unknown
- 1989-01-31 IE IE30289A patent/IE63097B1/en not_active IP Right Cessation
- 1989-02-01 CA CA000589803A patent/CA1341477C/en not_active Expired - Lifetime
1990
- 1990-08-01 DK DK183590A patent/DK183590A/da not_active Application Discontinuation
1994
- 1994-03-17 US US08/210,649 patent/US5676940A/en not_active Expired - Lifetime
1996
- 1996-02-29 HK HK35196A patent/HK35196A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
AU3038389A (en)	1989-08-25
HU211059B (en)	1995-10-30
DK183590D0 (da)	1990-08-01
HU891044D0 (en)	1990-11-28
IE890302L (en)	1989-08-02
NZ227812A (en)	1991-09-25
IL89124A0 (en)	1989-08-15
EP0327283A1 (en)	1989-08-09
CA1341477C (en)	2005-03-29
MY107079A (en)	1995-09-30
DE68908431T2 (de)	1993-12-23
ZA89766B (en)	1989-09-27
FI903827A7 (fi)	1990-08-01
WO1989006975A1 (en)	1989-08-10
PT89573B (pt)	1994-01-31
ATE93144T1 (de)	1993-09-15
ES2058490T3 (es)	1994-11-01
JPH03500050A (ja)	1991-01-10
DE68908431D1 (de)	1993-09-23
HK35196A (en)	1996-03-08
IL89124A (en)	1994-10-21
EP0397764A1 (en)	1990-11-22
FI903827A0 (fi)	1990-08-01
EP0327283B1 (en)	1993-08-18
KR900700132A (ko)	1990-08-11
US5676940A (en)	1997-10-14
HUT54214A (en)	1991-01-28
PT89573A (pt)	1989-10-04
AU629536B2 (en)	1992-10-08
IE63097B1 (en)	1995-03-22

Legal Events

Date	Code	Title	Description
2005-02-28	AHS	Application shelved for other reasons than non-payment

Publication	Publication Date	Title
DK183590D0 (da)	1990-08-01	Fremgangsmaade til reduktion af immunoglobulin e-responser
NL300387I1 (nl)	2009-07-01	Antilichaam tegen menselijke interleukine-6-receptor
NO980030D0 (no)	1998-01-05	Monoklonale antistoffer som binder CD40-L
DK388384D0 (da)	1984-08-10	Monoklone antistoffer med specifitet for membran-associerede antigene, deres fremstilling og anvendelse
DK81691A (da)	1991-05-02	Fremgangsmaade til forhindring eller reduktion af eosinofili
DK0504307T3 (da)	1994-03-21	Fremgangsmåde til behandling af septisk shock
DK355483A (da)	1984-02-19	Monoklonale antistoffer til krydsafstemning af humant vaev
DK0387873T3 (da)	1995-02-20	Anti-humant spermaantistof, fremstilling og anvendelse deraf
DK134487A (da)	1987-09-18	Monoklonalt antistof med affinitet for humant interleukin-2
FI924278A0 (fi)	1992-09-24	Bcrf1 antagonister foer skoetsel av epstein-barr-virusinfektioner.
FI924851A7 (fi)	1992-10-26	Monoklonaalisia IgM:n vastaisia vasta-aineita, niiden tuottaminen ja k äyttö sekä hybridoomia näiden tuottamista varten
ATE59860T1 (de)	1991-01-15	Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.